Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

Diabetes Epidemic Is a Worldwide Threat

  1. Eugene J. Barrett, MD, PhD
    Clinical Diabetes 2004 Jan; 22(1): 47-48. https://doi.org/10.2337/diaclin.22.1.47
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    Each triennium the International Diabetes Federation (IDF) hosts a worldwide Congress at which physicians, nurses, patients, and scientists share their knowledge, experience, and concerns regarding progress in the fight against diabetes. The most recent Congress was held in late August 2003, in Paris. More than 17,000 people participated. This included representatives of 180 national diabetes associations from around the world.

    Sir George Alberti, the outgoing president of the IDF, opened the meeting with a plenary address. He highlighted some of the demographic issues that are creating a worldwide threat from diabetes. Certainly, here in the United States, we see dramatic increases in the prevalence rates of diabetes and obesity. These are particular issues in several ethnic communities including Hispanic, Native-American, and African-American populations. We know very well that changes in lifestyle, including decreasing physical activity and expanded dietary intake, are major contributors.

    It should be no surprise that this same issue is occurring not only in other developed countries but increasingly within the developing world. There are epidemiological estimates that by 2025 there will be 250–300 million individuals worldwide with diabetes. This will be predominantly individuals with type 2 diabetes. Some of the populations experiencing an increased prevalence of diabetes in United States are being affected similarly in other countries. Thus, in Central and South America, in Africa, and in parts of Asia, the prevalence rates for diabetes are skyrocketing.

    The migration of populations to more urban settings, as well as increasing affluence in some countries (especially China and the Indian subcontinent), are strongly contributing to the increased prevalence. What may be particularly alarming is that in several populations (China and India again serve as examples), relatively modest increases in weight (compared with Caucasian populations) seem to be sufficient to provoke deterioration in insulin sensitivity and glucose tolerance.

    As a measure of how ill-equipped many countries are to deal with the diabetes epidemic, one Congress participant from the former Soviet republic of Azerbaijan told poignantly of her difficulty in obtaining insulin in adequate dosages for her daughter with diabetes. Many physicians are limited in the amounts of insulin they are allowed to prescribe. In some cases, they cannot give more than 20 units per day! At times, the insulin supply is unreliable with respect to either availability or quality. Blood glucose testing supplies are expensive and out of reach for many patients and families. Similarly, some of the medications used here to treat hyperglycemia (as well as hypertension and lipid disorders) are unavailable or too expensive for patients in developing countries.

    As you are aware, we have been only very modestly successful in implementing lifestyle changes that delay or prevent the onset of diabetes in United States. This is even after demonstrating conclusively in the National Institutes of Health’s Diabetes Prevention Program (DPP), and in studies in China and Scandinavia, that these changes work. As you can imagine, it is only that much more difficult to implement effective interventions in circumstances where resources are considerably more scarce. Both developed and developing nations will have to share strategies to avoid a worldwide scourge of diabetes and obesity during the 21st century.

    Certainly, any approach to this begins with education, both of our patients and of the public at large. The increasing recognition of diabetes as a serious disease and one of accelerating prevalence can only be helpful. We again have an advantage here in the United States with not only an informed physician community, but also a cadre of diabetes educators, nutritionists, and exercise physiologists. Indeed, in studies like the DPP, it was the efforts of these individuals that had major impact in decreasing the prevalence of transitioning from impaired glucose tolerance to frank diabetes. Developing countries frequently lack these important health care professionals.

    Soon, the Department of Health and Human Services will begin a Diabetes Detection Initiative (DDI) as a pilot project in 10 locales throughout the United States. It will focus particularly on communities disproportionately affected by diabetes. This effort will initially serve as an informational, educational, and interventional effort in those communities. It will allow assessment of the effectiveness of various types of community efforts. As such, it will provide an important opportunity to test models in communities that will improve the detection of diabetes and begin to drive the process of early intervention and prevention. Undoubtedly, it will also serve as a clarion call to the country to begin to face a burgeoning national health crisis. Hopefully, what we learn from programs like the DDI, as well as from a number of state and local intervention programs, will provide us and the world at large with improved strategies to detect and prevent diabetes.

    Footnotes

    • Eugene J. Barrett, MD, PhD, is president of the American Diabetes Association. He is a professor of medicine, pediatrics, and pharmacology at the University of Virginia and directs the University’s Diabetes Center in Charlottesville, Va.

    • American Diabetes Association
    PreviousNext
    Back to top

    In this Issue

    January 2004, 22(1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Clinical Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Diabetes Epidemic Is a Worldwide Threat
    (Your Name) has forwarded a page to you from Clinical Diabetes
    (Your Name) thought you would like to see this page from the Clinical Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Diabetes Epidemic Is a Worldwide Threat
    Eugene J. Barrett
    Clinical Diabetes Jan 2004, 22 (1) 47-48; DOI: 10.2337/diaclin.22.1.47

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Diabetes Epidemic Is a Worldwide Threat
    Eugene J. Barrett
    Clinical Diabetes Jan 2004, 22 (1) 47-48; DOI: 10.2337/diaclin.22.1.47
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
    • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
    • Timely News and Notes for Primary Care Providers from the American Diabetes Association
    Show more Departments

    Similar Articles

    Navigate

    • Current Issue
    • Papers in Press
    • Abridged Standards of Care
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.